Delta Investment Management LLC Has $501,000 Stock Position in Danaher Corporation $DHR

Key Points

• Delta Investment Management LLC increased its holdings in Danaher Corporation by 165.6% during the first quarter, reaching a stock position valued at $501,000.
• Danaher's recent earnings report revealed an EPS of $1.80, exceeding expectations and marking a 3.4% increase in revenue year-over-year.
• Institutional investors now own 79.05% of Danaher’s stock, with strong interest from other hedge funds also increasing their stakes in the company.

Delta Investment Management LLC raised its position in Danaher Corporation (NYSE:DHR - Free Report) by 165.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,446 shares of the conglomerate's stock after buying an additional 1,525 shares during the period. Delta Investment Management LLC's holdings in Danaher were worth $501,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. FAS Wealth Partners Inc. raised its position in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after purchasing an additional 1,639 shares during the last quarter. MGO One Seven LLC raised its holdings in shares of Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after buying an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher during the 1st quarter worth about $539,000. Horizon Financial Services LLC increased its position in Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after acquiring an additional 8,160 shares in the last quarter. Finally, EFG Asset Management Americas Corp. raised its stake in shares of Danaher by 13.1% in the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after acquiring an additional 4,191 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

DHR opened at $206.47 on Wednesday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a fifty day simple moving average of $201.02 and a 200 day simple moving average of $199.43. The stock has a market cap of $147.84 billion, a P/E ratio of 43.93, a P/E/G ratio of 2.90 and a beta of 0.73. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the company posted $1.72 EPS. The business's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Barclays reissued an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Wells Fargo & Company reduced their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $247.61.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.